Linagliptin-Associated Alopecia and Bullous Pemphigoid
Bullous pemphigoid is a chronic autoimmune blistering disease. Recently, several reports suggested dipeptidyl peptidase 4 (DPP-4) inhibitors, also known as gliptins, were a potential cause of drug-induced bullous pemphigoid but not of both bullous pemphigoid and alopecia areata together. Here we des...
Main Authors: | Ali Someili, Mohannad Abu Hilal, Khalid Azzam |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2019-09-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1207 |
Similar Items
Similar Items
-
Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid
by: Päivi Leisti, et al.
Published: (2024-09-01) -
The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study
by: Vaia Lambadiari, et al.
Published: (2021-02-01) -
Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients
by: Kamran Balighi, et al.
Published: (2022-11-01) -
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
by: Dana Shalmon, et al.
Published: (2024-04-01) -
A case of bullous pemphigoid induced by torsemide
by: Paul Wurtz, BS, et al.
Published: (2022-08-01)